Global Health Ltd Stock Price Today (NSE: MEDANTA)
Fundamental Score
Global Health Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Global Health Ltd share price today is ₹1120.40, up +0.00% on NSE/BSE as of 20 February 2026. Global Health Ltd (MEDANTA) is a Large-cap company in the Hospital sector with a market capitalisation of ₹33.50K (Cr). The 52-week high for MEDANTA share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 56.03x, MEDANTA is currently trading above its industry average P/E of 52.84x. The company has a Return on Equity (ROE) of 16.48% and a debt-to-equity ratio of 0.25.
Global Health Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Global Health Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Global Health Share Price: A Financial Stability Analysis
Within the Indian hospital sector, a critical yet often overlooked aspect is the variability in operational efficiency driven by diverse specialization focuses. This analysis examines the financial stability of Global Health Ltd, specifically focusing on its "Global Health share price" of ₹1142.699951. The company's Price-to-Earnings (PE) ratio stands at 56.03, which suggests investors have high expectations for future earnings growth. A key metric for assessing financial health is the Return on Capital Employed (ROCE), which for Global Health is reported at 19.74%.
A ROCE of 19.74% is generally considered healthy, indicating that Global Health is effectively generating profits from its invested capital. This high ROCE contributes significantly to the company's economic moat, suggesting a competitive advantage in its operational domain. The ability to consistently generate high returns attracts investors and helps the company reinvest in growth initiatives.
When comparing Global Health Ltd with its peers, such as
Nephro Care India Limited, it's crucial to consider the nuances of management quality and operational strategy. A deep dive into leadership effectiveness and execution could reveal differentiators. While detailed insight on Nephro Care's management wasn't provided, the comparison helps understand the broader industry landscape.It is important to note that this analysis is purely observational and based on currently available data. It is part of a broader 80-parameter fundamental audit of Global Health Ltd’s financial stability, verified by Sweta Mishra. This analysis does not constitute financial advice and should not be interpreted as a recommendation to buy or sell Global Health shares. Potential investors should conduct their own thorough due diligence and consult with a qualified financial advisor before making any investment decisions.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Global Health Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of MEDANTA across key market metrics for learning purposes.
Positive Indicators
11 factors identified
Strong Return on Equity (16.48%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (19.74%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (22.47%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Robust Profit Growth (21.09%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Consistent Growth Track Record (19.73% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (21.25% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (70.15% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.25)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (13.54x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹992.45 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
1 factors identified
Premium Valuation Risk (P/E: 56.03x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Global Health Ltd Financial Statements
Comprehensive financial data for Global Health Ltd including income statement, balance sheet and cash flow
About MEDANTA (Global Health Ltd)
Global Health Ltd (MEDANTA) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Hospital sector with a current market capitalisation of ₹33.50K (Cr). Global Health Ltd has delivered a Return on Equity (ROE) of 16.48% and a ROCE of 19.74%. The debt-to-equity ratio stands at 0.25, reflecting the company's capital structure. Investors tracking MEDANTA share price can monitor key metrics including P/E ratio, promoter holding of 33.01%, and quarterly earnings growth.
Company Details
Key Leadership
Corporate Events
MEDANTA Share Price: Frequently Asked Questions
What is the current share price of Global Health Ltd (MEDANTA)?
As of 20 Feb 2026, 05:06 am IST, Global Health Ltd share price is ₹1120.40. The MEDANTA stock has a market capitalisation of ₹33.50K (Cr) on NSE/BSE.
Is MEDANTA share price Overvalued or Undervalued?
MEDANTA share price is currently trading at a P/E ratio of 56.03x, compared to the industry average of 52.84x. Based on this relative valuation, the Global Health Ltd stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of MEDANTA share price?
The 52-week high of MEDANTA share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Global Health Ltd share price?
Key factors influencing MEDANTA share price include quarterly earnings growth (Sales Growth: 14.91%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Global Health Ltd a good stock for long-term investment?
Global Health Ltd shows a 5-year Profit Growth of 70.15% and an ROE of 16.48%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.25 before investing in MEDANTA shares.
How does Global Health Ltd compare with its industry peers?
Global Health Ltd competes with major peers in the Hospital. Investors should compare MEDANTA share price P/E of 56.03x and ROE of 16.48% against the industry averages to determine competitive standing.
What is the P/E ratio of MEDANTA and what does it mean?
MEDANTA share price has a P/E ratio of 56.03x compared to the industry average of 52.84x. Investors pay ₹56 for every ₹1 of annual earnings.
How is MEDANTA performing according to Bull Run's analysis?
MEDANTA has a Bull Run fundamental score of 61/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does MEDANTA belong to?
MEDANTA operates in the Hospital industry. This classification helps understand the competitive landscape and sector-specific trends affecting Global Health Ltd share price.
What is Return on Equity (ROE) and why is it important for MEDANTA?
MEDANTA has an ROE of 16.48%, which indicates excellent management efficiency. ROE measures how efficiently Global Health Ltd generates profits from shareholders capital.
How is MEDANTA debt-to-equity ratio and what does it indicate?
MEDANTA has a debt-to-equity ratio of 0.25, which indicates conservative financing with low financial risk.
What is MEDANTA dividend yield and is it a good dividend stock?
MEDANTA offers a dividend yield of 0.04%, meaning you receive ₹0.04 annual dividend for every ₹100 invested in Global Health Ltd shares.
How has MEDANTA share price grown over the past 5 years?
MEDANTA has achieved 5-year growth rates of: Sales Growth 19.73%, Profit Growth 70.15%, and EPS Growth 21.25%.
What is the promoter holding in MEDANTA and why does it matter?
Promoters hold 33.01% of MEDANTA shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Global Health Ltd.
What is MEDANTA market capitalisation category?
MEDANTA has a market capitalisation of ₹33498 crores, placing it in the Large-cap category.
How volatile is MEDANTA stock?
MEDANTA has a beta of N/A. A beta > 1 suggests the Global Health Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is MEDANTA operating profit margin trend?
MEDANTA has a 5-year average Operating Profit Margin (OPM) of 22.47%, indicating the company's operational efficiency.
How is MEDANTA quarterly performance?
Recent quarterly performance shows Global Health Ltd YoY Sales Growth of 14.91% and YoY Profit Growth of 21.09%.
What is the institutional holding pattern in MEDANTA?
MEDANTA has FII holding of 11.41% and DII holding of 12.97%. Significant institutional holding often suggests professional confidence in the Global Health Ltd stock.